Senkyunolide N
CAS No. 140694-58-2
Senkyunolide N ( )
Catalog No. M32423 CAS No. 140694-58-2
Senkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) .
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
10MG | 551 | In Stock |
|
50MG | Get Quote | In Stock |
|
100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameSenkyunolide N
-
NoteResearch use only, not for human use.
-
Brief DescriptionSenkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) .
-
DescriptionSenkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) . Senkyunolide N exhibits topoisomerase-I and -II enzyme inhibitory activity at concentrations of 100, 200 and 200 microg ml(-1). Senkyolide N has insecticidal effect.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number140694-58-2
-
Formula Weight226.3
-
Molecular FormulaC12H18O4
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Eupatorin
Eupatorin has antiproliferative and antiangiogenic effects. Eupatorin has antiproliferative and cytostatic effects on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.
-
Ibutamoren
Ibutamoren is a drug which acts as a potent, orally active growth hormone secretagogue, mimicking the GH stimulating action of the endogenous hormone ghrelin.
-
8-Epideoxyloganic ac...
8-Epideoxyloganic acid possesses bioactivities of analgesia, homeostasis and anti-inflammatory. It has the potential to serve as anti-inflammatory agents during oxidative stress, the inhibition of ROS production, possibly through modulation of NOX activity and/or the radical scavenging effect, and beta2 integrin expression in leucocytes.